UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

BMC cancer, 2009-01, Vol.9 (1), p.8-8, Article 8

2009

Volltextzugriff (PDF)

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

Acta obstetricia et gynecologica Scandinavica, 2012-04, Vol.91 (4), p.496-502

2012

Volltextzugriff (PDF)

Are we ready for translational research based on material and data from the Danish CancerBiobank and can we gain new knowledge from biobank registration?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2023-10, Vol.131 (10), p.536-542

2023

Volltextzugriff (PDF)

CT versus FDG‐PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Cancer medicine (Malden, MA), 2014-10, Vol.3 (5), p.1294-1301

2014

Volltextzugriff (PDF)

Association of CD31 and p53 With Survival of Ovarian Cancer Patients

Anticancer research, 2019-02, Vol.39 (2), p.567-576

2019

Volltextzugriff (PDF)

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-01, Vol.121 (1), p.38-44

2013

Volltextzugriff (PDF)

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-Control Study

Cancer causes & control, 2006-08, Vol.17 (6), p.821-829

2006

Volltextzugriff (PDF)

YKL-40 protein expression in normal adult human tissues--an immunohistochemical study

Journal of Molecular Histology, 2007-03, Vol.38 (1), p.33-43

2007

Volltextzugriff (PDF)

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab

PloS one, 2014-10, Vol.9 (10), p.e109430

2014

Volltextzugriff (PDF)

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

Cancer, 2003-07, Vol.98 (1), p.66-73

2003

Volltextzugriff (PDF)

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review

Cancer epidemiology, biomarkers & prevention, 2014-11, Vol.23 (11), p.2285-2295

2014

Volltextzugriff (PDF)

Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer

Scandinavian journal of clinical and laboratory investigation, 2014-09, Vol.74 (6), p.477-484

2014

Volltextzugriff (PDF)

Serum YKL-40 and gestational diabetes - an observational cohort study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2016-09, Vol.124 (9), p.770-775

2016

Volltextzugriff (PDF)

Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC)

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2006-10, Vol.114 (10), p.675-681

2006

Volltextzugriff (PDF)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008-05, Vol.116 (5), p.400-409

2008

Volltextzugriff (PDF)

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

Acta obstetricia et gynecologica Scandinavica, 2003-03, Vol.82 (3), p.287-293

2003

Volltextzugriff (PDF)

Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-08, Vol.118 (8), p.557-564

2010

Volltextzugriff (PDF)

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study

Gynecologic oncology, 2007-03, Vol.104 (3), p.508-515

2007

Volltextzugriff (PDF)

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: From the danish MALOVA ovarian carcinoma study

Cancer, 2004-06, Vol.100 (11), p.2387-2395

2004

Volltextzugriff (PDF)

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Gynecologic oncology, 2011-11, Vol.123 (2), p.308-313

2011

Volltextzugriff (PDF)

Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4051-4058

2004

Volltextzugriff (PDF)

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass

Gynecologic oncology, 2015-09, Vol.138 (3), p.640-646

2015

Volltextzugriff (PDF)

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2015-05, Vol.123 (5), p.401-409

2015

Volltextzugriff (PDF)

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-12, Vol.121 (12), p.1177-1186

2013

Volltextzugriff (PDF)

Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2012-10, Vol.120 (10), p.846-854

2012

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(112)

Publikationsform

Artikel
(120)

Sprache

Englisch
(119)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

YKL-40 tissue expression and plasma levels in patients with ovarian cancer

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

Are we ready for translational research based on material and data from the Danish CancerBiobank and can we gain new knowledge from biobank registration?

CT versus FDG‐PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab

Association of CD31 and p53 With Survival of Ovarian Cancer Patients

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-Control Study

YKL-40 protein expression in normal adult human tissues--an immunohistochemical study

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review

Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer

Serum YKL-40 and gestational diabetes - an observational cohort study

Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: From the danish MALOVA ovarian carcinoma study

A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer

Should CA-125 Response Criteria Be Preferred to Response Evaluation Criteria in Solid Tumors (RECIST) for Prognostication During Second-Line Chemotherapy of Ovarian Carcinoma?

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

Aktive Filter

Suchergebnisse filtern